SCHEDULE 13D/AAccepted Jun 23, 9:45 PM ET
Spyre Therapeutics, Inc. SCHEDULE 13D/A
Accepted (ET)
9:45 PM
Jun 23, 2026
Filed
Jun 23, 2026
Documents
1
Size
19.2 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.